Total planned funding: $448,809,639
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $448,809,639 |
Organizational Types
NGO | $117,754,923 |
Private Contractor | $96,026,979 |
Own Agency | $67,929,752 |
Host Country Government Agency | $62,296,684 |
Unknown | $41,491,499 |
University | $36,994,437 |
Implementing Agency | $7,949,070 |
Parastatal | $7,859,092 |
FBO | $4,170,045 |
Other USG Agency | $3,713,400 |
Multi-lateral Agency | $2,623,758 |
Program Areas
Treatment | $118,074,776 |
Prevention | $97,044,368 |
Care | $92,019,742 |
Governance and Systems | $60,382,762 |
Management and Operations | $49,830,546 |
Testing | $31,457,445 |
Budget Codes
HTXS: Treatment: Adult Treatment | $94,934,157 |
HVMS: Management and Operations | $49,830,546 |
HKID: Care: Orphans and Vulnerable Children | $33,725,535 |
HBHC: Care: Adult Care and Support | $31,978,119 |
HVCT: Testing: HIV Testing and Counseling | $31,457,445 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $30,686,217 |
OHSS: Health Systems Strengthening | $30,426,352 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,599,784 |
HVSI: Strategic Information | $22,838,509 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $21,812,451 |
HVTB: Care: TB/HIV | $16,726,524 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,109,427 |
PDTX: Treatment: Pediatric Treatment | $11,990,696 |
HTXD: Treatment: ARV Drugs | $11,149,923 |
PDCS: Care: Pediatric Care and Support | $9,589,564 |
HLAB: Laboratory Infrastructure | $7,117,901 |
HMBL: Biomedical Prevention: Blood Safety | $3,857,458 |
HMIN: Biomedical Prevention: Injection Safety | $2,979,031 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$55,776,872
Countries/Regions
USG Aggregated Agencies:
$44,848,948
Countries/Regions
Not Available:
$35,227,412
Countries/Regions